Intensity Therapeutics Inc (INTS) concluded trading on Wednesday at a closing price of $0.32, with 3.63 million shares of worth about $1.16 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -87.57% during that period and on July 23, 2025 the price saw a gain of about 4.23%. Currently the company’s common shares owned by public are about 15.26M shares, out of which, 14.05M shares are available for trading.
Stock saw a price change of -1.63% in past 5 days and over the past one month there was a price change of 7.38%. Year-to-date (YTD), INTS shares are showing a performance of -93.26% which decreased to -81.82% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.26 but also hit the highest price of $4.94 during that period. The average intraday trading volume for Intensity Therapeutics Inc shares is 2.24 million. The stock is currently trading 2.25% above its 20-day simple moving average (SMA20), while that difference is down -13.79% for SMA50 and it goes to -82.59% lower than SMA200.
Intensity Therapeutics Inc (NASDAQ: INTS) currently have 15.26M outstanding shares and institutions hold larger chunk of about 9.99% of that.
The stock has a current market capitalization of $8.34M and its 3Y-monthly beta is at 3.80. It has posted earnings per share of -$1.06 in the same period. It has Quick Ratio of 0.63 while making debt-to-equity ratio of 0.39. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for INTS, volatility over the week remained 8.86% while standing at 11.67% over the month.
Stock’s fiscal year EPS is expected to rise by 40.46% while it is estimated to increase by 16.75% in next year. EPS is likely to grow at an annualized rate of 12.46% for next 5-years, compared to annual growth of -23.29% made by the stock over the past 5-years.
